What question did this study set out to answer?

To establish evidence-based clinical practice recommendations on the role, safety, and application of sentinel node biopsy compared to axillary lymph node dissection in early-stage breast cancer.

September 13, 2005Journal of Clinical OncologyOpen Access

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

View Full Paper

Ask AI

Bookmark

Authors

GLGary H. LymanIntermountain Healthcare AGArmando E. GiulianoCedars-Sinai Medical Center MSMark R. SomerfieldAmerican Society of Clinical Oncology

Discussion

Member takes

Implication

Clinical practice guideline recommends sentinel lymph node biopsy over routine axillary dissection in early-stage breast cancer, highlighting reduced surgical morbidity without compromising staging.

Key Points

To establish evidence-based clinical practice recommendations on the role, safety, and application of sentinel node biopsy compared to axillary lymph node dissection in early-stage breast cancer.
Clinical practice guideline formulated by the American Society of Clinical Oncology based on an expert evaluation of available clinical trial evidence.
Evaluated staging accuracy, morbidity, and clinical outcomes of sentinel node biopsy versus complete axillary lymph node dissection in patients with clinically node-negative disease.
Sentinel node biopsy represents an appropriate alternative to routine axillary dissection for early-stage breast cancer with clinically negative axillary nodes, eliminating the need for completion dissection when negative.
Completion axillary dissection remains standard therapy if axillary metastases are detected, whereas isolated tumor cells identified via specialized pathology techniques have undetermined clinical significance.
Sentinel node biopsy produces significantly less morbidity than complete axillary dissection, although direct comparative data on long-term recurrence and survival remain undefined.

Cite This Study

Lyman et al. (2005) studied this question.

synapsesocial.com/papers/69df7296d5404a0bea593306 https://doi.org/10.1200/jco.2005.08.001

View Full Paper

Ask AI

Bookmark

September 13, 2005Journal of Clinical OncologyOpen Access

American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer

View Full Paper

Ask AI

Bookmark

Authors

GLGary H. LymanIntermountain Healthcare AGArmando E. GiulianoCedars-Sinai Medical Center MSMark R. SomerfieldAmerican Society of Clinical Oncology

Discussion

Member takes

Implication

Clinical practice guideline recommends sentinel lymph node biopsy over routine axillary dissection in early-stage breast cancer, highlighting reduced surgical morbidity without compromising staging.

Key Points

To establish evidence-based clinical practice recommendations on the role, safety, and application of sentinel node biopsy compared to axillary lymph node dissection in early-stage breast cancer.
Clinical practice guideline formulated by the American Society of Clinical Oncology based on an expert evaluation of available clinical trial evidence.
Evaluated staging accuracy, morbidity, and clinical outcomes of sentinel node biopsy versus complete axillary lymph node dissection in patients with clinically node-negative disease.
Sentinel node biopsy represents an appropriate alternative to routine axillary dissection for early-stage breast cancer with clinically negative axillary nodes, eliminating the need for completion dissection when negative.
Completion axillary dissection remains standard therapy if axillary metastases are detected, whereas isolated tumor cells identified via specialized pathology techniques have undetermined clinical significance.
Sentinel node biopsy produces significantly less morbidity than complete axillary dissection, although direct comparative data on long-term recurrence and survival remain undefined.

Cite This Study

Lyman et al. (2005) studied this question.

synapsesocial.com/papers/69df7296d5404a0bea593306 https://doi.org/10.1200/jco.2005.08.001

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark